Search Results

Committee recommended that the TNM staging system be used to stage SCLC in both routine practice and clinical trial design. 4 The standard treatment for LS-SCLC is definitive chemoradiation therapy without surgery; however, whether surgery has a role in

experience . J Clin Oncol 1991 ; 9 : 1138 – 1150 . 19 Hacker NF Berek JS Lagasse LD . Primary cytoreductive surgery for epithelial ovarian cancer . Obstet Gynecol 1983 ; 61 : 413 – 420 . 20 Hoskins WJ Bundy BN Thigpen JT . The

. Philadelphia, PA : Lippincott Williams and Wilkins , 2000 . 2 Passlick B . Can surgery improve local control in small cell lung cancer? Lung Cancer 2001 ; 33 ( Suppl 1 ): S147 – S151 . 3 Kohman LJ . Is there a place for surgery in

Viterbo R Greenberg RE Al-Saleem T Uzzo RG . Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland . J Urol 2005 ; 174 : 446 – 450 . 14 Nelson CP Wolf JS Jr . Comparison

Cancer suggest consideration of radiation therapy (RT) with concurrent chemotherapy in larger T2 or T3 lesions not amenable to up-front organ-sparing surgery. 3 However, minimal published data, either retrospective or prospective, exists for patients

As the incidence of ductal carcinoma in situ (DCIS) has increased, so has the number of DCIS survivors. 1 Most patients with DCIS are treated with breast-conserving surgery (BCS). 2 Radiation therapy (RT) and antiestrogen therapy (AET) have been

Use of minimally invasive surgery (MIS) in the management of early-stage cervical cancer (ESCC), previously considered an acceptable alternative to open surgery, 1 was recently challenged by results of the Laparoscopic Approach to Cervical

recommendations. No randomized trials exist, and the results of small retrospective case series have led to contradictory conclusions. A study by the Rare Cancer Network showed improved survival with CRT alone compared with surgery/radiotherapy (RT) or surgery

recurrent disease. Although adjuvant chemotherapy improves survival for all patients with resected PDAC, 2 , 3 up to 50% of patients will not initiate postoperative chemotherapy, typically because of poor performance status after major surgery. 4 – 6 A

positive peritoneal cytology, who represent a high-risk subgroup, and identify the 20% to 30% of patients with presumed localized cancer who in fact have low-volume peritoneal disease. 13 , 14 Surgery Surgery is the primary treatment for localized